Weekly Health Care Wrap-Up – November 22, 2013
Weekly health care wrap-up – November 22, 2013
Filed under: drug treatment programs in maryland
On Tuesday, Centers for Medicare & Medicaid Services (CMS) Deputy Chief Information Officer Henry Chao was called before the House Energy and Commerce Subcommittee on Oversight and Investigations for a hearing on data security on the exchange …
Read more on Lexology (registration)
Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for …
Filed under: drug treatment programs in maryland
"This new agreement not only expands Eisai's territory for commercialization, but it also prioritizes our global development program for BELVIQ," said Jack Lief, Arena's President and Chief Executive Officer. … our collaboration with Eisai provides …
Read more on GTN News
FDA Approves Merck's NOXAFIL® (posaconazole) Delayed-Release Tablets
Filed under: drug treatment programs in maryland
WHITEHOUSE STATION, N.J. — Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL® (posaconazole) 100 mg delayed-release tablets. … who are at high …
Read more on The Herald | HeraldOnline.com (press release)
CEL-SCI Conducts Meeting of North American Clinical Centers to Support …
Filed under: drug treatment programs in maryland
The U.S. Food and Drug Administration (FDA) has already granted orphan drug designation to Multikine in the treatment of advanced primary head and neck cancer. CEL-SCI, through the newly hired Clinical Research Organization (CROs) Aptiv Solutions and …
Read more on Wall Street Journal